Ceftazidime-avibactam versus doripenem for the treatment of complicated urinary tract infections, including acute pyelonephritis: RECAPTURE, a phase 3 randomized …

FM Wagenlehner, JD Sobel, P Newell… - Clinical Infectious …, 2016 - academic.oup.com
Background. The global emergence of carbapenem-resistant Enterobacteriaceae highlights
the urgent need to reduce carbapenem dependence. The phase 3 RECAPTURE program …

Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 …

FM Wagenlehner, JD Sobel, P Newell… - Clinical Infectious …, 2016 - search.ebscohost.com
Background. The global emergence of carbapenem-resistant Enterobacteriaceae highlights
the urgent need to reduce carbapenem dependence. The phase 3 RECAPTURE program …

Ceftazidime-avibactam versus doripenem for the treatment of complicated urinary tract infections, including acute pyelonephritis: RECAPTURE, a phase 3 randomized …

FM Wagenlehner, JD Sobel, P Newell, J Armstrong… - 2016 - cabidigitallibrary.org
Background. The global emergence of carbapenem-resistant Enterobacteriaceae highlights
the urgent need to reduce carbapenem dependence. The phase 3 RECAPTURE program …

[PDF][PDF] Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 …

FM Wagenlehner, JD Sobel, P Newell… - Clinical Infectious …, 2016 - webs.fcm.unc.edu.ar
Background. The global emergence of carbapenem-resistant Enterobacteriaceae highlights
the urgent need to reduce carbapenem dependence. The phase 3 RECAPTURE program …

[PDF][PDF] Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 …

FM Wagenlehner, JD Sobel… - Clinical …, 2016 - clinicainfectologica2hnc.webs.fcm …
Background. The global emergence of carbapenem-resistant Enterobacteriaceae highlights
the urgent need to reduce carbapenem dependence. The phase 3 RECAPTURE program …

Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 …

FM Wagenlehner, JD Sobel… - … publication of the …, 2016 - pubmed.ncbi.nlm.nih.gov
Background The global emergence of carbapenem-resistant Enterobacteriaceae highlights
the urgent need to reduce carbapenem dependence. The phase 3 RECAPTURE program …

[PDF][PDF] Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 …

FM Wagenlehner, JD Sobel, P Newell… - Clinical Infectious …, 2016 - scienceopen.com
Background. The global emergence of carbapenem-resistant Enterobacteriaceae highlights
the urgent need to reduce carbapenem dependence. The phase 3 RECAPTURE program …

[HTML][HTML] Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 …

FM Wagenlehner, JD Sobel, P Newell… - … Diseases: An Official …, 2016 - ncbi.nlm.nih.gov
Background. The global emergence of carbapenem-resistant Enterobacteriaceae highlights
the urgent need to reduce carbapenem dependence. The phase 3 RECAPTURE program …

[PDF][PDF] Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 …

FM Wagenlehner, JD Sobel… - Clinical Infectious …, 2016 - pdfs.semanticscholar.org
Background. The global emergence of carbapenem-resistant Enterobacteriaceae highlights
the urgent need to reduce carbapenem dependence. The phase 3 RECAPTURE program …